SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccin
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the full year ended Dece
Does VAXART, INC. (VXRT) have what it takes to be a top stock pick for momentum investors?
Amid the broad-market rally, shares of Equillium (EQ), Phunware (PHUN), Super Micro Computer (SMCI), Vaxart (VXRT) and Dianthus Therapeutics (DNTH) have more than doubled this year.
VAXART, INC. (VXRT) reached a significant support level, and could be a good pick for investors from a technical perspective.
Vaxart, Inc. (NASDAQ:VXRT ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Andrei Floroiu - President and CEO James Cummings - Chief Medical Officer Phil Lee - CFO B
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief
Investing in biotech stock can provide investors with immense rewards but also substantial risks. The key is finding the right balance.
After losing some value lately, a hammer chart pattern has been formed for VAXART, INC. (VXRT), indicating that the stock has found support.
Start Time: 16:30 January 1, 0000 5:01 PM ET Vaxart, Inc. (NASDAQ:VXRT ) Q2 2023 Earnings Conference Call August 03, 2023, 16:30 PM ET Company Participants Andrei Floroiu - President and CEO James Cum
VAXART, INC. (VXRT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19.

Why Is Vaxart (VXRT) Stock Down 25% Today?

09:29am, Wednesday, 07'th Jun 2023
Vaxart (NASDAQ: VXRT ) stock is taking a beating on Wednesday as investors react to the company announcing a proposed public share offering. According to a press release from Vaxart, the company is ho
Novavax and Vaxart both were early favorites in the coronavirus vaccine race -- but the two companies fell behind. Since then, they've cut costs and shifted strategies.
Company to provide a detailed overview of its norovirus clinical program
Vaxart, Inc. (NASDAQ:VXRT ) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ET Company Participants Brant Biehn - Senior Vice President, Business Operations Andrei Floroiu - Chief Executive Of
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE